文献速递脑血管病外科神经重症

可溶性晚期糖基化终末产物受体作为蛛网膜下腔出血症状性血管痉挛的生物标志物

Soluble receptor for advanced glycation end products as a biomarker of symptomatic vasospasm in subarachnoid hemorrhage.
PubMed 文献 · J Neurosurg · 2019-11-01

该研究评估血浆可溶性晚期糖基化终末产物受体(sRAGE)作为蛛网膜下腔出血(SAH)后症状性血管痉挛(SVS)生物标志物的价值。研究比较了27例SAH患者(7例SVS,20例无SVS)第5至14天的血浆sRAGE水平,并在大鼠SAH模型中检测了血浆sRAGE及RAGE和血红素加氧酶-1(HO-1)表达。结果显示SVS组相对血浆sRAGE水平显著低于非SVS组,第7天与第5天比值0.84为预测SVS的合适截断值;大鼠SAH模型血浆sRAGE显著低于假手术组,RAGE和HO-1表达增强。作者认为血浆sRAGE可作为预测SAH后SVS的潜在生物标志物。

要点

  • SVS组相对血浆sRAGE水平显著低于非SVS组。
  • 第7天与第5天相对血浆sRAGE比值0.84为预测SVS的合适截断值。
  • 大鼠SAH模型血浆sRAGE显著低于假手术组,RAGE和HO-1表达增强。

核心结论

  • 血浆sRAGE水平可作为预测SAH后症状性血管痉挛的潜在生物标志物。

研究设计与样本

  • 研究纳入27例SAH患者(7例伴SVS,20例不伴SVS),检测SAH后第5天至第14天的血浆sRAGE水平并进行比较。
  • 同时在大鼠SAH模型中检测血浆sRAGE水平及RAGE和血红素加氧酶-1(HO-1)的表达。

主要发现

  • SVS组患者的相对血浆sRAGE水平显著低于非SVS组。
  • 第7天与第5天相对血浆sRAGE比值的0.84截断值被认为适合用于预测SVS。
  • 大鼠SAH模型血浆sRAGE水平显著低于假手术组,SAH组RAGE和HO-1表达较非SAH组增强。

关键数值与推荐

  • 预测SVS的相对血浆sRAGE水平(第7天 vs 第5天)截断值为0.84。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The receptor for advanced glycation end products (RAGE) is a membrane protein associated with the induction of oxidative stress and inflammation in several pathological conditions. Previous studies have demonstrated that soluble RAGE (sRAGE) acts as a decoy for RAGE and protects cells against RAGE-mediated injury. The authors and other groups have reported that the expression of RAGE increases after brain ischemia and subarachnoid hemorrhage (SAH), and deletion of RAGE or overexpression of sRAGE improves neuronal survival. It has also been demonstrated that the plasma sRAGE level could be a predictor of the outcome after ischemic stroke. This study aimed to evaluate plasma sRAGE as a biomarker for symptomatic vasospasm (SVS) in SAH patients, as well as a rat model. METHODS: The authors measured and compared plasma sRAGE levels in 27 SAH patients (7 with SVS and 20 without SVS) from day 5 to day 14 post-SAH. They also examined plasma sRAGE levels and expression of RAGE and heme oxygenase-1 (HO-1) in a rat SAH model. RESULTS: The relative plasma sRAGE levels were significantly lower in the SVS group than in the non-SVS group of patients. A cut-off value of 0.84 for predicting SVS was considered to be appropriate for the relative plasma sRAGE levels on day 7 versus day 5. In the rat SAH model, plasma sRAGE levels were significantly lower than those in sham-treated rats, and the expressions of RAGE and HO-1 were enhanced in the SAH group compared with the non-SAH group. CONCLUSIONS: Plasma sRAGE levels can be used as a potential biomarker for predicting SVS after SAH.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Aida Y, Kamide T, Ishii H, et al. Soluble receptor for advanced glycation end products as a biomarker of symptomatic vasospasm in subarachnoid hemorrhage. J Neurosurg. 2019. PMID: 31675694. doi:10.3171/2019.8.JNS191269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。